Astrazeneca Share Discussion Threads

[patdavey] 30/7/2018 12:02

But then if you started your curve a fortnight later in mid-January, AZN would have caught GSK up by now.

[patdavey] 30/7/2018 12:02

But then if you started your curve a fortnight later in mid-January, AZN would have caught GSK up by now.

[bountyhunter] 30/7/2018 11:36

Catching up, next time I post I'm hoping AZN will be ahead!
AZN has the better pipeline imho

[buywell3] 21/7/2018 11:43

.......... Prion Disease ........


Add this one to Alzheimers' and Parkinsons




Dementia = Prion Disease

But a lot of olde doctors liked to get diseases named after them 100+ years ago

[bountyhunter] 19/7/2018 11:28

gap with GSK being closed :)

[bountyhunter] 18/7/2018 12:04

Capital Group holding inceased to > 5%

[bountyhunter] 18/7/2018 12:01

that's one way to reduce any potential initial WTO tariffs/bottlenecks!

[bountyhunter] 18/7/2018 10:02

the quitest threads are the best! e.g. my BQE thread
- I can live without the trolls, egotists, rampers and derampers, life is too short!

[bluemango] 18/7/2018 09:50

Indeed.

Extraordinarily quiet thread, btw, given what's occurring, and results so near.

[bountyhunter] 18/7/2018 09:37

I'm not saying it's a negative going forwards, I expect that gap to narrow! :)

[bluemango] 17/7/2018 17:02

Ok although I don't see that as a "but"; it's more of an "and".

Because you're giving a reason for the rises to be sustained and built on, rather than investors fretting that gravity might begin to kick in.

[bountyhunter] 17/7/2018 16:44

Yes that's good news but there is still some catching up to do vs GSK since the start of the year - I had expected the chart below to develop the other way around especially given AZN's superior prospects/pipeline (imho) and GSK's higher yield.

[bluemango] 17/7/2018 16:17

New highs.

[bluemango] 16/7/2018 12:37

Interim results due in 10 days, on 26th July.

[smcni1968] 12/7/2018 17:08

Pfizer coming back for another look?

[smcni1968] 18/5/2018 20:43

The US listing looks like it's going to end up flat on the day

[bountyhunter] 18/5/2018 08:44

well those results didn't do the comparison chart much good, more catching up to do now!



but I like the growth in China and pipeline here vs GSK

[steeplejack] 18/5/2018 08:12

AstraZeneca PLC18 May 2018 07:00Q1 2018 ResultsEncouraging launches and the performance of newer medicines underpin reiterated guidanceAs expected, the Product Sales performance benefitted from strong launches and the continued growth of newer medicines and China, offset by the erosion of Crestor sales. Progress was made on overall cost discipline, while the level of Externalisation Revenue, divestment timing and investment in launches impacted the overall results. Patients continued to benefit from the progress of the pipeline and AstraZeneca's plans remain on track, with the Company continuing to anticipate Product Sales growth this year, weighted to the second half.

[bountyhunter] 18/5/2018 07:19

from the Q1 results:

A China sales increase of 31% (22% at CER) to $1,025m. For the first time, quarterly sales of more than $1bn were achieved, underpinned by the launch of Tagrisso.

[smcni1968] 17/5/2018 16:50

Results tomorrow

[bountyhunter] 17/5/2018 13:08

still needs to catch up a bit with GSK since I showed an interest!



(and no-one mention dividends!)

AZN has the most promising pipeline however imho

[miahkaysor] 11/5/2018 16:20

I would look into HEMO (aim listed) flying as i write this!!!!




Nai.dyor.imho etc

[silverballs] 11/5/2018 12:32

Price is very volatile,but seems to keep wanting to push higher.

[gateside] 01/5/2018 19:15

Broker upgrade maybe?

[smcni1968] 01/5/2018 16:55

Weak pound perhaps?